4//SEC Filing
Smith Ryan Lewis 4
Accession 0001213900-25-074501
CIK 0001690080other
Filed
Aug 10, 8:00 PM ET
Accepted
Aug 11, 7:35 PM ET
Size
6.6 KB
Accession
0001213900-25-074501
Insider Transaction Report
Form 4
Smith Ryan Lewis
Director
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2025-08-08+771,044→ 771,044 totalExercise: $3.01Exp: 2035-08-08→ Common Stock (771,044 underlying)
Holdings
- 167,181
Common Stock
Footnotes (2)
- [F1]The options were granted under the 2025 Second Supplemental Option Plan of the Issuer. The options vested immediately, but are not exercisable until stockholder approval of the 2025 Second Supplemental Option Plan is received. If stockholder approval is not received prior to August 8, 2026, the options will be cancelled.
- [F2]Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as a director of the Issuer.
Documents
Issuer
180 Life Sciences Corp.
CIK 0001690080
Entity typeother
Related Parties
1- filerCIK 0001619129
Filing Metadata
- Form type
- 4
- Filed
- Aug 10, 8:00 PM ET
- Accepted
- Aug 11, 7:35 PM ET
- Size
- 6.6 KB